DocGo (DCGO) Expected to Announce Quarterly Earnings on Monday

Key Points

• Q1 2026 earnings due after the market closes on Monday, May 11 at 5:00 PM ET; analysts expect EPS of ($0.02) and revenue of $72.476M.
• Shares trade around $0.67 (12‑month range $0.49–$2.45) with a market cap of about $66.26M and a negative P/E (-0.36), while short‑term volume recently ran below the stock's average.
• Analyst views are mixed (three Buy, three Hold, one Sell) with a consensus rating of "Hold" and a $2.38 average target, and institutional investors own roughly 56.44% of the stock after several small new positions.

DocGo (NASDAQ:DCGO - Get Free Report) is anticipated to issue its Q1 2026 results after the market closes on Monday, May 11th. Analysts expect the company to announce earnings of ($0.02) per share and revenue of $72.4760 million for the quarter. Parties may review the information on the company's upcoming Q1 2026 earning report for the latest details on the call scheduled for Monday, May 11, 2026 at 5:00 PM ET.

DocGo Price Performance

DCGO traded down $0.00 on Monday, hitting $0.67. 154,789 shares of the stock were exchanged, compared to its average volume of 958,117. DocGo has a 12 month low of $0.49 and a 12 month high of $2.45. The business has a 50-day moving average of $0.65 and a two-hundred day moving average of $0.84. The firm has a market capitalization of $66.26 million, a price-to-earnings ratio of -0.36 and a beta of 1.02.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Cerity Partners LLC acquired a new position in DocGo during the second quarter worth about $37,000. Strs Ohio acquired a new position in DocGo during the first quarter worth about $76,000. Engineers Gate Manager LP acquired a new position in DocGo during the second quarter worth about $52,000. Neuberger Berman Group LLC acquired a new position in DocGo during the fourth quarter worth about $29,000. Finally, Public Employees Retirement System of Ohio acquired a new position in shares of DocGo in the fourth quarter valued at approximately $40,000. Institutional investors and hedge funds own 56.44% of the company's stock.

Analyst Ratings Changes

DCGO has been the subject of several recent analyst reports. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $3.00 price objective on shares of DocGo in a research report on Tuesday, March 17th. Stifel Nicolaus cut their price objective on shares of DocGo from $4.00 to $2.50 and set a "buy" rating for the company in a research report on Tuesday, March 17th. Canaccord Genuity Group lowered their target price on DocGo from $1.50 to $1.00 and set a "hold" rating for the company in a research note on Wednesday, March 25th. Finally, Needham & Company LLC reissued a "buy" rating and set a $3.00 target price on shares of DocGo in a research note on Tuesday, March 17th. Three investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $2.38.

DocGo Company Profile

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.